Cue Health: David Arida
Diagnostic testing firm Cue Health has appointed David Arida as chief operating officer. Arida joins Cue from Dexcom, a diabetes care technology company, where he served in multiple senior operational roles since 2011, most recently as senior vice president of global manufacturing operations. Prior to Dexcom, Arida held a number of management, consulting, or engineering positions at Alere (now Abbott), Amylin Pharmaceuticals (now AstraZeneca), and PRTM (now PWC).
Berkeley Lights: Siddhartha Kadia
Berkeley Lights has appointed Siddhartha Kadia to its board of directors, increasing the board's size to nine members. Kadia was president and CEO of EAG Laboratories, a company acquired by Eurofins Scientific in 2017, and, before that, president of life sciences at Life Technologies. He also serves on the boards of IsoPlexis and BioSkryb. Kadia holds a PhD in biomedical engineering from Johns Hopkins University.
LGC: Euan O'Sullivan
Euan O'Sullivan has been appointed CEO of international life sciences measurement and testing company LGC, effective immediately.
O'Sullivan, previously LGC's president and chief operating officer, succeeds Tim Robinson, who served as CEO from May 2013. Robinson will now become chairman of the group. O'Sullivan joined LGC in 2007 as non-executive director, taking over as corporate development director in 2010. He was later appointed managing director of the Standards division and joined the board as executive director in 2017.
For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.